Last reviewed · How we verify
AP01
At a glance
| Generic name | AP01 |
|---|---|
| Also known as | Pirfenidone Solution |
| Sponsor | Avalyn Pharma Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis (PHASE2)
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |